MENU
+Compare
VYGR
Stock ticker: NASDAQ
AS OF
May 23 closing price
Price
$2.92
Change
-$0.23 (-7.30%)
Capitalization
161.58M

VYGR Voyager Therapeutics Forecast, Technical & Fundamental Analysis

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases... Show more

Industry: #Biotechnology
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for VYGR with price predictions
May 23, 2025

VYGR sees MACD Histogram just turned negative

VYGR saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on May 22, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 39 instances where the indicator turned negative. In of the 39 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 21, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on VYGR as a result. In of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VYGR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where VYGR advanced for three days, in of 268 cases, the price rose further within the following month. The odds of a continued upward trend are .

VYGR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 100 cases where VYGR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.593) is normal, around the industry mean (16.323). P/E Ratio (6.000) is within average values for comparable stocks, (59.117). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.182). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (2.528) is also within normal values, averaging (278.956).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. VYGR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VYGR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

VYGR is expected to report earnings to fall 2.75% to -51 cents per share on July 31

Voyager Therapeutics VYGR Stock Earnings Reports
Q2'25
Est.
$-0.52
Q1'25
Missed
by $0.08
Q4'24
Missed
by $0.22
Q3'24
Beat
by $0.29
Q2'24
Beat
by $0.23
The last earnings report on May 06 showed earnings per share of -52 cents, missing the estimate of -44 cents. With 307.22K shares outstanding, the current market capitalization sits at 161.58M.
A.I. Advisor
published General Information

General Information

a developer of gene therapies for fatal and debilitating diseases of the central nervous system

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
75 Hayden Avenue
Phone
+1 857 259-5340
Employees
162
Web
https://www.voyagertherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FWOCX16.20N/A
N/A
Fidelity Advisor Women's Leadership C
QASGX24.31-0.02
-0.08%
Federated Hermes MDT Small Cap Growth A
NEJCX6.04-0.01
-0.17%
Natixis Vaughan Nelson Small Cap C
WVMIX11.03-0.04
-0.36%
William Blair Mid Cap Value I
HFMTX33.10-0.22
-0.66%
Hartford MidCap R5

VYGR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with TRDA. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-7.30%
TRDA - VYGR
50%
Loosely correlated
-1.57%
RGNX - VYGR
49%
Loosely correlated
+0.73%
IMNM - VYGR
48%
Loosely correlated
+0.35%
RCKT - VYGR
47%
Loosely correlated
-4.86%
XNCR - VYGR
46%
Loosely correlated
-1.56%
More